Mcgill University Medical Podcast Series

Hey there, and welcome to The MUMPS: The McGill University Medical Podcast Series! This is a podcast geared towards aspiring, training or practicing health care professionals who are looking to keep up to date with the latest medical research going on at McGill and its affiliated institutions. Tune in monthly as your hosts Russ and Eric chat with basic science and clinical researchers behind some of McGill University's most current, influential and thought-provoking medical research.

About PodLP

PodLP is the leading podcast app for feature phones. With 10M+ installs in nearly every country, PodLP is available for KaiOS on the KaiStore and JioStore, as well as Cloud Phone and Android. If you're interested in promoting "Mcgill University Medical Podcast Series" on PodLP, contact sales@podlp.com.

Screenshots are mockup renders of PodLP for KaiOS. Actual design may vary based on platform, operating system, and app version.

Episodes (4)

Feb 9, 2019 Episode 4 - Dr. Richard Menzies and Dr. Jonathan Campbell - 4 months of Rifampin for latent TB
Jul 12, 2018 Episode 3 - Matthew Dankner - Dual MAPK inhibition in a subset of BRAF mutant melanomas
May 13, 2018 Episode 2 - Devin Abrahami - DPP-4 inhibitors and incidence of IBD among patients with DMII

Mcgill University Medical Podcast Series

Feb 9, 2019
19 minutes
23 MB

In this episode, we're joined by Dr. Richard Menzies and Dr. Jonathan Campbell from the McGill Respiratory Epidemiology and Clinical Research Unit to discuss the results of their multi-center RCT comparing 4 months of rifampin to 9 months of isoniazid for the treatment of latent TB. Their findings are outlined in two papers, entitled "Four Months of Rifampin or Nine Months of Isoniazid for Latent TB in Adults" and "Safety and Side Effects of Rifampin Versus Isoniazid in Children" published in the August 2018 issue of the New England Journal of Medicine.

Mcgill University Medical Podcast Series

Episode 4 - Dr. Richard Menzies and Dr. Jonathan Campbell - 4 months of Rifampin for latent TB

Mcgill University Medical Podcast Series

00:00 -18:48